Published in J Cyst Fibros on August 01, 2005
Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic (2008) 1.34
Saturation of the human phenome. Curr Genomics (2010) 1.09
Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun (2008) 1.06
The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis. BMC Pulm Med (2012) 0.92
Genetic interaction of GSH metabolic pathway genes in cystic fibrosis. BMC Med Genet (2013) 0.90
IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability. Hum Genet (2016) 0.79
Analysis of CFTR Gene Mutations in Children with Cystic Fibrosis, First Report from North-East of Iran. Iran J Basic Med Sci (2013) 0.79
Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study. BMC Med Genet (2014) 0.79
The role for neutrophil extracellular traps in cystic fibrosis autoimmunity. JCI Insight (2016) 0.77
TNF-alpha polymorphisms as a potential modifier gene in the cystic fibrosis. Int J Mol Epidemiol Genet (2014) 0.77
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet (2011) 7.15
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med (2015) 5.86
Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell (2013) 3.97
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol (2003) 3.70
Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am J Respir Crit Care Med (2010) 2.78
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis (2010) 2.48
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA (2010) 2.47
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol (2009) 2.27
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol (2011) 2.10
Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods (2005) 2.09
Reduced neonatal lung function and wheezing illnesses during the first 5 years of life. Eur Respir J (2012) 2.06
Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial. Pediatrics (2007) 2.06
Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet (2005) 1.93
A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med (2013) 1.87
Solid-phase and bead-based cytokine immunoassay: a comparison. Methods (2006) 1.87
Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology (2011) 1.80
The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Respir Crit Care Med (2014) 1.78
Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS One (2012) 1.76
Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog (2013) 1.74
Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol (2005) 1.70
Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev (2014) 1.70
Otitis media and its consequences: beyond the earache. Lancet Infect Dis (2010) 1.68
Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis (2009) 1.65
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS One (2012) 1.63
Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial. Pediatrics (2005) 1.59
Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol (2009) 1.56
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J (2013) 1.56
Excess early postnatal weight gain leads to thicker and stiffer arteries in young children. J Clin Endocrinol Metab (2013) 1.52
Atopic disease and exhaled nitric oxide in an unselected population of young adults. Ann Allergy Asthma Immunol (2008) 1.52
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis (2012) 1.50
Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J Infect (2012) 1.50
Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis (2011) 1.49
Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med (2014) 1.49
Lack of long-term effects of high-dose inhaled beclomethasone for respiratory syncytial virus bronchiolitis: a randomized placebo-controlled trial. Pediatr Infect Dis J (2014) 1.46
C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med (2003) 1.46
Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Thorax (2010) 1.45
Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One (2012) 1.43
Respiratory pathogens in children with and without respiratory symptoms. J Pediatr (2008) 1.40
A novel fluorescent sensor for measurement of CFTR function by flow cytometry. Cytometry A (2013) 1.38
Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics (2007) 1.37
Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov. and Asaccharospora gen. nov. Int J Syst Evol Microbiol (2014) 1.34
Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis (2012) 1.32
Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum (2002) 1.30
Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS One (2011) 1.25
Return of Haemophilus influenzae type b infections. Lancet (2003) 1.24
Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol (2008) 1.22
A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med (2007) 1.22
Analysis of multiple SNPs in genetic association studies: comparison of three multi-locus methods to prioritize and select SNPs. Genet Epidemiol (2007) 1.21
Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA (2010) 1.21
Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr (2010) 1.18
Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery (2007) 1.16
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One (2010) 1.15
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis (2014) 1.15
Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr (2007) 1.15
Parental smoking and vascular damage in their 5-year-old children. Pediatrics (2011) 1.14
Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep (2011) 1.14
Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr (2010) 1.13
Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases. Pediatr Blood Cancer (2011) 1.12
Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am J Hum Genet (2008) 1.12
Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccine Immunol (2008) 1.11
Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol (2006) 1.11
Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics (2008) 1.10
Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol (2003) 1.10
Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol (2013) 1.09
Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet (2002) 1.09
Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest (2004) 1.09
Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis (2014) 1.08
Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax (2007) 1.08
Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008. Clin Infect Dis (2011) 1.07
Viral respiratory infections in cystic fibrosis. J Cyst Fibros (2005) 1.06
The influence of neonatal lung function on rhinovirus-associated wheeze. Am J Respir Crit Care Med (2010) 1.05
Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine (2011) 1.04
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant (2008) 1.03
Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin Infect Dis (2001) 1.02
Outcome of assisted ventilation for acute respiratory failure in cystic fibrosis. Intensive Care Med (2006) 1.02
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine (2009) 1.02
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. Pediatr Infect Dis J (2011) 1.01
Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits. Vaccine (2009) 1.01
Impulse oscillometry: a measure for airway obstruction. Pediatr Pulmonol (2003) 1.00
Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. Microbes Infect (2005) 1.00
Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv (2007) 1.00
Superiority of trans-oral over trans-nasal sampling in detecting Streptococcus pneumoniae colonization in adults. PLoS One (2013) 0.99
Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev (2009) 0.99
26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition (2011) 0.99
Respiratory pathogens in respiratory tract illnesses during the first year of life: a birth cohort study. Pediatr Infect Dis J (2009) 0.99
Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res (2007) 0.99
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration (2008) 0.99
Birth prevalence and survival in cystic fibrosis: a national cohort study in the Netherlands. Chest (2005) 0.98
Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine (2008) 0.98
Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis (2012) 0.97
Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis (2009) 0.97